We studied the effect of ramipril on proteinuria and mild hypertension in a 21-year-old patient affected by glycogen storage disease type I non-A. After few months of therapy we obtained a decrease in total urine protein excretion that later re-increased in spite of the high dose of ACE inhibitor. Even if ACE inhibitors are the only effective therapy for GSD I nephropathy, further studies are requested
Ramipril treatment in a patient with glycogen storage disease I non-A / M.L. Giannì, M. Bonvissuto, M. Gallieni, C. Testolin, E. Racchi, E. Riva. - In: JOURNAL OF INHERITED METABOLIC DISEASE. - ISSN 0141-8955. - 25:6(2002), pp. 515-516.
Ramipril treatment in a patient with glycogen storage disease I non-A
M.L. GiannìPrimo
;M. Gallieni;E. RivaUltimo
2002
Abstract
We studied the effect of ramipril on proteinuria and mild hypertension in a 21-year-old patient affected by glycogen storage disease type I non-A. After few months of therapy we obtained a decrease in total urine protein excretion that later re-increased in spite of the high dose of ACE inhibitor. Even if ACE inhibitors are the only effective therapy for GSD I nephropathy, further studies are requested
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
